HCID 57420172, compound → HCID 57420174, compound
Reaction equation
[Cl:1][C:2]1[C:7]([Cl:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:14][CH2:13][N:12]([CH2:15][CH2:16][CH2:17][C:18]([O:20][C:21]2[CH:30]=[C:29]3[C:24]([CH2:25][CH2:26][C:27](=[O:31])[NH:28]3)=[CH:23][CH:22]=2)=[O:19])[CH2:11][CH2:10]1.Cl.COC1C=CC=CC=1N1CCN(CCCC(OC2C=C3C(CCC(=O)N3)=CC=2)=O)CC1>>[ClH:1].[Cl:1][C:2]1[C:7]([Cl:8])=[CH:6][CH:5]=[CH:4][C:3]=1[N:9]1[CH2:10][CH2:11][N:12]([CH2:15][CH2:16][CH2:17][C:18]([O:20][C:21]2[CH:30]=[C:29]3[C:24]([CH2:25][CH2:26][C:27](=[O:31])[NH:28]3)=[CH:23][CH:22]=2)=[O:19])[CH2:13][CH2:14]1Participants
3
Procedure
2-Oxo-1,2,3,4-tetrahydroquinolin-7-yl 4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butanoate hydrochloride (20b) (Scheme 3) was prepared from the compound 19b according to the protocol described for the compound 20a (Example 29). The hydrochloride salt 20b gave satisfactory 1H NMR spectral data. White solid, 0.11 g (98%). MS (ESI): m/z=462.1 (M+).
Sources & evidence
- ORD record
- ord-90ede9d1dad9465aac6f9404582fbb49
- Source dataset
- uspto-grants-2012_08
- Patent number
- US08247420B2
Reaction notes
Loading…